upadacitinib
abbvie
['spondylitis', 'upadacitinib', 'select-axis', 'select,axis,2']
results of the select-axis 2 study supported the efficacy and safety profile of #upadacitinib in patients with active ankylosing spondylitis who had an inadequate response to biologic dmard therapy. #eular2023
Clinical News for Connected Physicians. Everything you need to enhance your clinical approach to improving patient care.